The hepatic glycogenoses.
D001706:Biopsy; D002648:Child; D002740:Chlorothiazide / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D005959:Glucosidases / Q000378:metabolism; D005964:Glucosyltransferases / Q000378:metabolism; D006008:Glycogen Storage Disease / Q000145:classification* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000401:mortality / Q000628:therapy; D005953:Glycogen Storage Disease Type I / Q000378:metabolism; D006026:Glycoside Hydrolases / Q000378:metabolism; D006527:Hepatolenticular Degeneration / Q000150:complications; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D007003:Hypoglycemia / Q000175:diagnosis / Q000209:etiology; D007223:Infant; D008107:Liver Diseases / Q000201:enzymology*; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D009461:Neurologic Manifestations; D012737:Sex Factors; D013997:Time Factors
D008112:Liver Glycogen; D002740:Chlorothiazide; D005964:Glucosyltransferases; D005959:Glucosidases; D006026:Glycoside Hydrolases; D003981:Diazoxide